Abstract Multiple K v channel complexes contribute to total K v current in numerous cell types and usually subserve different physiological functions. Identifying the complete compliment of functional K v channel subunits in cells is a prerequisite to understanding regulatory function. It was the goal of this work to determine the complete K v subunit compliment that contribute to functional K v currents in rat small mesenteric artery (SMA) myocytes as a prelude to studying channel regulation. Using RNA prepared from freshly dispersed myocytes, high levels of K v 1.2, 1.5, and 2.1 and lower levels of K v 7.4 a-subunit expressions were demonstrated by quantitative PCR and confirmed by Western blotting. Selective inhibitors correolide (K v 1; COR), stromatoxin (K v 2.1; ScTx), and linopirdine (K v 7.4; LINO) decreased K v current at ?40 mV in SMA by 46 ± 4, 48 ± 4, and 6.5 ± 2 %, respectively, and K v current in SMA was insensitive to a-dendrotoxin. Contractions of SMA segments pretreated with 100 nmol/L phenylephrine were enhanced by 27 ± 3, 30 ± 8, and 7 ± 3 % of the response to 120 mmol/L KCl by COR, ScTX, and LINO, respectively. The presence of K v 6.1, 9.3, b1.1, and b1.2 was demonstrated by RT-PCR using myocyte RNA with expressions of K v b1.2 and K v 9.3 about tenfold higher than K v b1.1 and K v 6.1, respectively. Selective inhibitors of K v 1.3, 3.4, 4.1, and 4.3 channels also found at the RNA and/or protein level had no significant effect on K v current or contraction. These results suggest that K v current in rat SMA myocytes are dominated equally by two major components consisting of K v 1.2-1.5-b1.2 and K v 2.1-9.3 channels along with a smaller contribution from K v 7.4 channels but differences in voltage dependence of activation allows all three to provide significant contributions to SMA function at physiological voltages.
Introduction
Voltage-gated K ? channels (K v ) play an important role in the regulation of contraction in arterial smooth muscle (ASM) [1] . This is due to the central role they play in determining membrane potential [2] and consequently, the open probability of voltage-gated Ca 2? channels [3] . The latter represent an important source of activator Ca 2? for tonic contraction in ASM especially in resistance arteries [3] . K v channels (KCN) are also the targets of extracellular and intracellular signaling that contribute to the regulation of arterial function in vivo as well as to the remodeling associated with vascular disease and aging [4] .
KCN comprise a large gene family consisting of poreforming a-subunits that are often associated with transmembrane or intracellular accessory subunits [5, 6] . Most KCN subfamilies have multiple members some of which are subject to alternative splicing, heteromultimeric assembly, and post-translational modification [7, 8] . As a result, there is a large, potential pool of KCN subunit combinations with different functional characteristics [4, 7, 8] .
Past studies have demonstrated the presence of multiple K v subunits in ASM cells (ASMC) from several vascular sites based on mRNA and/or protein expression [9] [10] [11] [12] [13] [14] [15] [16] , biophysical properties and/or pharmacology of K v currents in isolated cells [14] [15] [16] [17] [18] [19] [20] , and/or responses of artery segments to K ? channel reagents [15] [16] [17] [18] [19] [20] . In general, studies at the mRNA level have suggested expression of a larger number of K v subunits than studies at the protein or functional level [9, 11, 13] . However, this could be due in part to limitations in available reagents such as antibodies or selective inhibitors producing false positive as well as false negative results.
Such an analysis is important because various K v subunits have different functional properties [4, 7, 8, 21] and are differentially regulated [22, 23] . Furthermore, the presence of accessory subunits can confer unique regulatory function to a-subunits [5, 24] . It was previously shown that KCN in ASMC are inhibited by increases in intracellular Ca 2? [25, 26] which likely contributes to the membrane depolarization associated with agonist activation [2] . However, nothing is known of the specific K v components that contribute to this effect. Thus, determining the complete composition of functionally significant K v subunit combinations is a necessary prerequisite to understanding their contribution to this as well as other regulatory processes in ASM [27] . Accordingly, the goal of this study was to determine using multiple methods the K v components that contribute to the functional activity of ASMCs in rat small mesenteric artery (SMA) as a model arterial site. It is important to note that the functional K v composition is likely to vary among different anatomical sites in both sizeand organ-specific manner contributing to site-specific regulatory function [1, 4] .
Methods

Animals and Tissues
Arteries from 16 to 18 week old male Wistar Kyoto rats were used for RNA and protein isolation, for single-cell patch clamp studies and for mechanical studies. Animals were handled in accordance with the Guide for the Care and Use of Laboratory Animals. Animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of the Lankenau Institute for Medical Research.
RNA Isolation and RT-PCR
Following removal from animals, segments of SMA and tail artery (TA) were cannulated with a blunted 22 gage needle and air was passed through the vessel lumen by applying gentle pressure [28] . This process has been reported to remove endothelial cells and was confirmed herein using intact segments by the lack of a response to 1 lmol/L acetylcholine following contractions induced by 120 mmol/L KCl under isometric conditions. Total RNA was isolated from tissues by homogenization in Tri-reagent (RiboPure, Ambion, Austin, TX). RNA was also prepared from ASMCs enzymatically dispersed from SMA and TA by papain and collagenase treatment [26] . Total RNA was also prepared from brain by homogenization in guanidinium isothiocyanate followed by centrifugation through a CsCl step gradient as described [29] . RNA concentration was determined spectrophotometrically (NanoDrop 2000c, Thermo Sci., Wilmington, DC). First-strand cDNA was synthesized from 1 lg total RNA using SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA) and random hexamer primers [29] . First-strand reactions were also performed in which the reverse transcriptase enzyme was omitted (RT-reactions) as a negative control for firststrand synthesis. Conventional PCR with gene-specific primers was performed using Titanium Taq polymerase (Invitrogen) [29] . Additional PCR templates included 500 ng of rat brain cDNA (positive RT control) and 500 ng of rat genomic DNA and water as positive and negative PCR controls, respectively.
Real Time qPCR
Real time (quantitative) PCR was performed with AmpliTaq Gold polymerase and gene-specific expression assays (Eurofins MWG Operon, Huntsville, AL) using a Mastercycler ep realplex (Eppendorf, Westbury, NY) as described [30] . The abundance of K v b1.1 versus b1.2, K v 6.1 versus K v 9.3 and K v 7.4 versus K v 2.1 were compared using the 2 ÀDDC t method directly comparing expression in the same samples [31] .
Protein Analysis
Segments of SMA along with TA, thoracic aorta, left ventricular free wall, and/or brain were rapidly isolated, and placed in cold isolation buffer containing protease and phosphatase inhibitors (Complete mini, Roche Diagnostics, Basel, Switzerland; Halt, Pierce Biotechnology, Rockford, IL, USA). The tissues were cleaned, cut into small pieces, and homogenized in RIPA buffer as described [30] . Protein concentration was determined using the BioRad DC Protein Assay with albumin as the standard.
Immunoblotting
Aliquots of proteins (5-30 lg) were size fractionated by SDS-PAGE using 7 % Tris-acetate gels [30] . Proteins were electroblotted to polyvinylidene difluoride (PVDF) membranes which were incubated in blocking buffer (5 % dry milk plus 0.1 % Triton X-100 in PBS) for 1 h at room temperature then with primary antibody in blocking buffer overnight at 4°C. Membranes were rinsed, incubated with HRP-conjugated secondary antibodies, and treated with chemiluminescent reagent (Clarity, BioRad). Finally, abundance was quantitated by image analysis (FluorS MultiImager and Image One Software, BioRad Corp., Hercules, CA) as described [30] .
Immunoprecipitation
Protein lysates (200 lg) were incubated overnight with antibodies (2-6 lg) at 4°C to form immunocomplexes. The latter were captured with precleared protein G-agarose beads by gentile mixing for 4 h at 4°C followed by centrifugation. The supernatant was removed and the beads were washed 39 with cold RIPA buffer [30] . SDS loading buffer was added to the beads and heated at 70°C for 10 min. Aliquots of precleared lysate, supernatant, and immunocomplexes were separated by SDS-PAGE using 7 % Tris-acetate gels [30] .
Immunofluorescence
Dispersed cells were plated on glass coverslips, fixed with cold 4 % paraformaldehyde, washed, and incubated with blocking buffer for 30 min on ice. They were then incubated with primary antibody overnight at 4°C, washed with cold PBS (93 for 5 min) and incubated with Cy3-conjugated secondary antibody in blocking buffer at room temperature for 60 min in the absence of light. The coverslips were again washed with cold PBS (3X for 5 min), briefly air dried and covered with VectaShield mounting media with DAPI (Vector Labs., Burlingame, CA). The slides were covered with glass and viewed using an inverted microscope (Zeiss Axioplan, Thornwood, NY) with a Plan Neofluar 40X/1.3 oil immersion objective. Images were captured with an Axiocam CCD camera using AxioVision software (Zeiss).
Electrophysiology
ASMCs freshly isolated from SMA were used for the determination of K v currents by whole cell voltage clamp methods at room temperature (*21°C) as previously described in detail [26] .
Contractile Studies
Second-or third-order mesenteric artery branches were cut into 2-3 mm long segments and mounted in vitro at their optimum length for isometric force development in a temperature-controlled bath at 37°C as previously described [32] . Following an initial 2-3 h equilibration period, responses to 120 mmol/L KCl were recorded in duplicate. Following recovery, responses to K v inhibitors were obtained as described in the Results section. Force data were digitized (MacLab 8e; AD Instruments, Colorado Springs, CO) at a sampling interval of 50 ms and stored on a computer (Macintosh G4, Apple Computers, Cupertino, CA) for off-line analysis. Tangential wall stress was calculated from force measurements using segment wet weight and dimensions as described [32] . 
Statistics
Statistical analysis was performed using SigmaPlot v12.0 (Systat Software Inc.; San Jose, CA). Comparisons of current-voltage data between groups were made with one or two way analysis of variance (ANOVA). When the ANOVA produced a significant P value, comparisons were made using the Bonferroni test for paired data, or using Dunnett's Test for multiple comparisons. Probability values less than 0.05 were considered to be statistically significant. Data are given as mean ± 1 SEM.
Results
Gene expression of Shaker K v 1 a-subunits was surveyed by conventional PCR (cPCR) using RNA isolated from ASMC of SMA and TA. Expressions of K v 1.2 and K v 1. a-subunits were found at high levels at both arterial sites (Fig. 1a) . K v 1.2 and K v 1.5 immunofluorescence was also detected in isolated myocytes from SMA (Fig. 1b) . The contribution of K v 1.2 and K v 1.5 channels to whole cell K v currents was assessed from the response to the selective K v 1 channel inhibitor correolide [33] . Following inhibition of BK Ca channels by 100 nmol/L iberiotoxin (IbTx) and L-type Ca ? -channels with 1 lmol/L nifedipine, the addition of 10 lmol/L correolide produced a slowly developing inhibition of K ? current that averaged 46 ± 4 % (n = 8) of total at a test voltage of ?40 mV (Fig. 2a) and was voltage independent (Fig. 2b) . The correolide-insensitive current appeared to be kinetically distinct in that it activated and inactivated more slowly than the correolide-sensitive K ? current (Fig. 2b left) . To demonstrate that correolide-sensitive K v channels are functionally important, we tested the effect of correolide on contractile responses of SMA segments. Segments precontracted with 100 nmol/L phenylephrine (28 ± 3 % of the response to 120 mmol/L KCl) exhibited robust but slowly developing responses to 10 lmol/L correolide that averaged 27 ± 3 % of the response to 120 mmol/L KCl (Fig. 2c) .
We previously reported gene expression of other members of the Shaker K v 1 family in intact SMA segments that are also known to be correolide-sensitive, specifically K v 1.1 and 1.3 [29] . We found expression of K v 1.3 but not K v 1.1 in RNA from both SMA and TA myocytes (Fig. 3a) .
Also a low abundance K v 1.3 protein band appeared to be present in lysates from all tissues but at much lower levels compared to brain while K v 1.1 protein was not present in arteries (Fig. 3b) . However, neither hongotoxin (a K v 1.1 and K v 1.3 inhibitor) nor margatoxin (a K v 1.3 inhibitor) had any significant effect on whole cell K ? currents in SMA myocytes (Fig. 3c ) or on contraction of SMA segments (data not shown).
To determine if K v 1.2 subunits are present in homotetrameric or heterotetrameric assemblies, we evaluated the effects of a-dendrotoxin on SMA K v currents [34] . Exposure to 100 nmol/L a-dendrotoxin had no significant effect on whole cell K ? currents in SMA myocytes (data not shown). To confirm the activity of the toxin, we heterologously expressed K v 1.2 and K v 1.5 channels in CHO cells [30] and found that K ? current in the former but not the latter was inhibited by 100 nmol/L a-dendrotoxin (data not shown). These results suggest that essentially all K v 1.2 subunits in SMA are present in heterotetrameric combination with K v 1.5 subunits but does not rule out the presence of homotetrameric K v 1.5 channels.
In many tissues, K v 1 a-subunits are associated with accessory b-subunits [6] . We surveyed the expressions of the three gene families of K v b subunits by cPCR. We found mRNA expression for only K v b1.1 and b1.2 in ASMCs from SMA ( Fig. 4a ) and compared the relative abundance of these two subunits by quantitative PCR (qPCR). When the expression of K v b1.2 was compared directly to that of K v b1.1 in the same samples by 2 ÀDDC t analysis, the ratio averaged 13.7 ± 1.7 (n = 9) for SMA and 10.8 ± 1.9 (n = 9) for TA (Fig. 4B) . When analyzed by Western blot of whole tissue lysates, only expression of K v b1.2 could be unequivocally detected in arterial protein lysates (Fig. 4c ). An association between K v b1.2 and K v 1.2 (and by implication with K v 1.5) could be demonstrated in both arterial and brain lysates by immunoprecipitation (Fig. 4d) . Combined, these results suggest that K v 1.2 and K v 1.5 are present as a heterotetramer along with K v b1.2 in SMA but the presence of homotetrameric K v 1.5 channels cannot be ruled out.
Next, we surveyed gene expression of K v 2 a-subunits in intact arteries [10, 19, 30] by cPCR using RNA isolated from ASMC of SMA as well as TA. We found expression of K v 2.1 but not K v 2.2 in ASMCs RNA (Fig. 5a ), and by immunofluorescence in both isolated cells and tissue sections (Fig. 5b) . The latter shows the presence of K v 2.1 immunofluorescence in the adventitia as well as in the media of SMA suggesting expression of K v 2.1 in nerve terminals and/or fibroblasts as well as in ASMCs.
The contribution of K v 2.1 channels to whole cell K v current was assessed using stromatoxin-1 (ScTx) a selective K v 2.1 inhibitor [35] . Following inhibition of BK Ca and Ca V channels with IbTx and Nif, addition of l00 nmol/L ScTx produced a rapid inhibition of whole cell K ? current ( Fig. 6a, b) that averaged 48 ± 4 % at ?40 mV (n = 6). In addition, isolated SMA segments precontracted with 100 nmol/L phenylephrine or 30 nmol/L of a thromboxane A 2 (PGH 2 ) analog (U46619; Upjohn Co, Kalamazoo, MI) (36 ± 5 % of the response to 120 mmol/L KCl) demonstrated robust contractions to ScTx (Fig. 6c) that averaged 30 ± 8 % of the response to 120 mmol/L KCL (n = 15). These results demonstrate that K v 2.1 channels also contribute to the regulation of contractile function in SMA myocytes. K v 2.1 subunits have been shown to associate with several accessory subunits that modify their biophysical properties as well as cell surface expression [4, 36, 37] . We surveyed expression of accessory subunits known to associate with K v 2.1 and found expressions of only K v 6.1 and K v 9.3 by cPCR (Fig. 7a) . We determined the relative abundance of these two transcripts by qPCR and found expression of K v 9.3 to be about 15-and 30-fold higher than K v 6.1 in SMA and TA, respectively (Fig. 7b) . We were unable to demonstrate protein expression of these two accessory subunits using commercially available antibodies by cellular IF, or by Western blotting using arterial lysates or lysates from HEK cells overexpressing V5-epitope tagged constructs of K v 6.1 and K v 9.3 subunits (data not shown).
Previous studies suggested the presence of a rapidly inactivating, A-type K v current in vascular myocytes [38] . Some members of the K v 3 gene family have been shown to exhibit this phenotype so we surveyed expression of this K v family by cPCR and found expression of only K v 3.4 in SMA and TA RNA (Fig. 8a) . Immunofluorescence suggested the presence of K v 3.4 immunoreactivity at the cell surface in SMA myocytes (Fig. 8b) and Western blot analysis showed an immunoreactive protein band at a slightly larger size in arterial lysates compared to brain lysates. Since mature K v 3.4 protein at the plasma membrane is glycosylated [39] we treated arterial and brain lysates with PNGase F which decreased the size of the protein in brain but had no effect on proteins in arterial lysates suggesting that the latter was not K v 3.4 protein (Fig. 8c) . More importantly, BDS-I and BDS-II, selective inhibitors of K v 3.4 channels [40] , had no significant effect on whole cell K v currents in SMA myocytes (Fig. 8d) and no significant contractile effect in isolated SMA segments (Fig. 8e) . These results suggest that K v 3.4 channels if present are not functionally active in SMA myocytes.
Members of the K v 4 gene family have also been shown to exhibit an A-current-like phenotype so we also surveyed expression of members of this K v family. We found expressions of K v 4.1 and K v 4.3 by cPCR in RNA from SMA cells and by Western blot analysis of tissue lysates from LV, arteries, and brain but not by cellular IF (Fig. 9a-c) . The 73 kD band considered to be K v 4.3 protein was insensitive to PNGase F as expected [41] . However, toxin inhibitors of K v 4 channels, heteropodatoxin and phrixotoxin, had no significant effect on K v currents in SMA myocytes (Fig. 9d) , and heteropodatoxin had no contractile effect in isolated segments precontracted with phenylephrine (Fig. 9e) .
Recently, members of the KCNQ (K v 7) family have been shown to be expressed in vascular tissue and suggested to play a functional role [15, 42] . Accordingly, we surveyed expression of K v 7 family a-subunits in RNA from SMA. Using cPCR, we found expressions of K v 7.1, 7.3, 7.4, and 7.5 in RNA from intact SMA (Fig. 10a) but only K v 7.4 and 7.5 in RNA isolated from ASMCs. By cPCR, expressions of K v 7.1 and 7.4 were found in the left ventricular free wall and K v 7.2, 7.3, 7.4, and 7.5 expressions were found in brain RNA. As K v 7.4 was the dominant transcript in myocyte RNA, we compared its expression to that of K v 2.1 by qPCR. Expression of K v 2.1 was significantly higher than that of K v 7.4 in SMA myocyte RNA as well as in brain RNA (Fig. 10b) . K v 7.4 currents in SMA myocytes were determined by recording K v current in the presence of 100 nmol/L IbTx, 1 lmol/L Nif, 10 lmol/L COR, l00 nmol/L ScTx, and 1 mmol/L TEA after subtracting non-voltage dependent currents as described by Mackie et al. [15] . For the latter, currents recorded between -80 and -60 mV were extrapolated to all voltages representing non-voltage dependent, leak currents. Using such methods, K v 7.4 currents averaged 6.5 ± 1.5 % of total K v current at ?40 mV (Fig. 10c, d ) but this value was strongly voltage dependent so that K v 7.4 accounted for about 40 % of total K v current at -50 mV (Fig. 10e) .
Finally, we used the selective inhibitor linopirdine to test for a functional role of K v 7.4 channels in SMA [42] . Linopirdine (10 lmol/l) had no significant contractile effect under basal conditions (data not shown) and had only a small effect (7 ± 3 % of the KCl response) after treatment with 100 nmol/L phenylephrine in the presence of BK Ca inhibition (Fig. 10f) . A similar result was observed when segments were precontracted with 30 nmol/L U46619 (data not shown). In contrast, the K v inhibitor XE-991 (10 lmol/L) [42] produced a large response equal to that of KCl under similar conditions (Fig. 10g) .
Discussion
The results of this study demonstrate that functionally significant K v channel complexes in SMA myocytes include heteromultimeric combinations of K v 1.2-K v 1.5-K v b1.2 and a likely combination of K v 2.1 with K v 9.3 subunits. The latter combination could not be unambiguously demonstrated at the protein level due to limitations in antibodies to test for the presence and association of K v 9.3 with K v 2.1 subunits. These two components account for 90-95 % of total K v current when recorded at high test voltages (?40 mV), and contribute equally to total K v current and to the regulation of arterial contraction in SMA. K v 7.4 channels are also functionally present in SMA and appear to provide a smaller contribution compared to the other two components but their contribution is strongly voltage dependent and at physiologically relevant voltages (-55 to -25 mV) [2] all three components contribute functionally.
K v Subunit Expression
Since smooth muscle cells represent the most abundant cell type in arteries it would be expected that the expression profile of K v subunits in SMA myocytes would be similar if not identical (at least qualitatively) to that of intact tissue. Indeed this expectation was confirmed in this study with high levels of expression of K v 1.2, 1.5, 2.1, and 7.4 asubunits demonstrated in ASMCs. We also found expressions of K v 1.1, 3.2b, and 3.3 a-subunits in whole tissue RNA but not in ASMCs suggesting that these subunits may be expressed in other cell types in intact arteries [12] .
K v b1.1 and b1.2 were the only K v b subunits expressed in SMA myocytes. qPCR showed that expression of K v b1.2 was more than an order of magnitude higher than that of K v b1.1 subunits. We found expression of K v b1.2 but not K v b1.1 by Western blotting in SMA lysates and found them to be associated with K v 1.2 by immunoprecipitation. Based upon the insensitivity of native K v 1 (ScTx-insensitive) currents to the K v 1.2 inhibitor a-dendrotoxin [34] , these results suggest the expression of a channel complex composed of K v 1.2-K v 1.5-K v b1.2 subunits in SMA myocytes, however, the stoichiometry of the a/b association cannot be determined from these results.
Gene expressions of K v 6.1 and K v 9.3 subunits known to associate with K v 2.1 [36, 37] were found in RNA prepared from dispersed SMA myocytes with much higher levels of K v 9.3 expression. Although we could not confirm protein expression of K v 9.3 in this study, based upon electrophysiological evidence presented in a companion study [43] , it is highly likely that K v 2.1 subunits are associated with K v 9.3 subunits in SMA myocytes. In support of this conclusion, Zhong et al. [20] recently showed plasma membrane expression of K v 9.3 as well as K v 2.1 subunits in rat middle cerebral artery myocytes using proximity ligation analysis to amplify signals from ''weak'' antibodies.
Functional K v Channel Expression
Correolide [33] and stromatoxin [35] , selective inhibitors of K v 1 and K v 2 channels, respectively, each inhibited about half of the total K v current in SMA myocytes and produced quantitatively similar contractile responses in SMA segments confirming expression results. Selective inhibitors of K v 3 (heteropodatoxin and phrixotoxin) and K v 4 channels (BDS-I and II) had no effect on K v currents or on contraction in segments pretreated with either PE or a PGH 2 -analog which was surprising as we found evidence suggesting protein expressions of K v 3.4, 4.1, and 4.3 asubunits in SMA. It is possible that these subunits may not be trafficked to the plasma membrane, may be associated with inhibitory partners that prevent cell surface expression or activity, or may be post-translationally modified in a manner that inhibits functional activity [7, 8, 44, 45] . Alternatively, these may be false positive results due to limitations in reagents used which is likely the case with K v 3.4 subunits.
Members of the KCNQ gene family have been reported in several arteries of mouse, rat, and human [15, 16, 46] . Most studies agree that K v 7.4 is the most abundant transcript with expression of K v 7.4 protein primarily demonstrated by immunofluorescence in dispersed myocytes, and by pharmacological responses of cells or segments [16, 42] . Our results show expressions of KCNQ4 transcripts in SMA myocytes at lower levels compared to K v 2.1 subunits and a smaller contribution to functional activity of K v 7.4 channels compared to K v 1 and K v 2.1 channels. This finding seems at odds with the comparative results shown in Fig. 10e but the contribution of K v 7.4-containing channels to total K v current decreases rapidly with increasing (depolarized) voltages. Since agonist-mediated depolarizations may reach values close to -20 mV, this may be an explanation for the apparent smaller contribution of K v 7.4 channels in precontracted segments [2] .
It is interesting that for the most part significant effects have been observed with K v 7 activators rather than inhibitors but some of the latter studies were performed using XE-199 which is now known to be non-selective. This is somewhat similar to the effects of K ATP channels in arteries: small effects of inhibitors (depending upon conditions) but large effects of activators. This suggests that K v 7 channels may be more important in vasodilation associated with local (tissue) regulation of blood flow for example. It is likely that regional and species differences along with differences in experimental conditions contribute to these observations.
Physiological Significance
The results of the present study suggest that K v 1.2-1.5-b1.2 and K v 2.1-K v 9.3 subunit combinations are the dominant K v components in SMA with K v 7.4 channels providing a smaller but functionally significant contribution that decrease with depolarization above -50 mV. Since there is some overlap in the biophysical properties of these channel complexes [4, 15, 21, 47] as well as their contribution to cell function (e.g., myogenic regulation) [19, 42, 48] the question arises as to why the apparent redundancy? Many cell types such as cardiac myocytes express multiple K v channel complexes but they usually subserve different aspects of cell function [49, 50] . This redundancy in ASMC may be important because mutations and/or epigenetic modifications of a single K v gene or its protein product that cause loss of function could compromise arterial regulation as they do in the heart [50, 51] . Since K v 1-and K v 2.1-as well as K v 7.4-containing channels contribute to the regulation of smooth muscle contraction including myogenic responses, loss of function of one without a commensurate increase in the others would theoretically lead to vasoconstriction and loss of vasodilator reserve which would be pro-hypertensive but would not result in complete loss of K v functionality in ASM.
The apparent redundancy may also be important by increasing the repertoire of cellular regulatory mechanisms. For example, only K v 1.5 possesses PKG consensus regulatory sequences while both K v 1.2 and K v 1.5 but not K v 2.1 contain N-linked glycosylation sites (Prosite, http://ca. expasy.org/prosite/). Both of these post-translational mechanisms have been shown to influence channel functional properties [52, 53] . Further, K v b1.2 is sensitive to redox conditions [54] , and K v 7.4 is the target for perivascular adipose tissue-released regulatory mediators and hydrogen sulfide [55] .
Study Limitations
There are several potential limitations that could affect the conclusions of this study. For one, antibodies have potential limitations that must be considered. The sensitivity and selectively of the antibodies used to detect K v subunits herein have been validated by both cell immunofluorescence and Western blot using CHO or HEK cells stably expressing these channels some of which were V5 tagged [30] . K v b1 antibodies were also tested using protein lysates from hearts of K v b1 knock-out and control mice (kindly supplied by Dr. J M Nerbonne, Washington Univ.). For other K v subunits, the antibodies have been evaluated primarily by the presence of protein bands in Western blots at the size expected for either the translated product or post-translationally modified ones based upon (a) citations in the literature or in protein data bases (http://www. expasy.org/) and (b) by its presence in tissues (brain and/or left ventricle) where expression status has been confirmed. Although these are not the best criteria, they represent necessary tests.
We have used total tissue lysates to test for the presence of K v subunits by Western blot. The small amount of arterial tissue from the rat makes it difficult to obtain sufficient protein mass from dispersed cells without pooling from an unacceptably large number of animals. Expanding isolated cells in culture is also unacceptable due to phenotypic modulation that occurs under such conditions [56] . Proteins from sources other than smooth muscle cells may contribute to the total protein population in these lysates but smooth muscle cells are the most abundant cell type in resistance arteries so results are less likely to produce false positives. However, this approach does not discriminate between subcellular locations of K v subunits and may overestimate plasma membrane (functional) levels. It was not the goal of this study to characterize subcellular distribution but rather to demonstrate expressions of K v subunits at the protein level in tissue lysates as a part of the total study of gene, protein, and functional expression. Notably, all conclusions concerning protein expression are supported by functional studies.
Since K v 2.1 appears to be expressed in the adventitia, perhaps in nerve terminals, ScTx could potentially release transmitter from those terminals that could contribute to the contractile response. In these studies, we used both phenylephrine and U44619 as agonists to precontract isolated arterial segments, and the relative effect of the two agonists was not significantly different (data not shown). While a contribution of transmitter release from perivascular nerves with ScTx may be present,it would be unlikely to alter the conclusions of the study.
Selective inhibitors of K v channel subunits were used to determine their contributions to total K v current as well as for their ability to modulate contractile function of isolated segments. In general, the inhibitors employed are accepted to be selective for specific a subunits and were used at levels 4-tenfold higher than their reported IC 50 . It would have been desirable to generate a dose-response relation for channel inhibitors to determine maximal efficacy but this was not practical. The effects of some inhibitors such as correolide require a substantial amount of time to achieve a steady state response. In general, it is difficult to maintain stability and quality of voltage-clamped myocytes for the time required to perform a dose-response analysis. For inhibitors constituted in organic solvents (e.g., DMSO), dilutions into the perfusion solution were never less than 1000:1 and the effects of solvent were always tested independently as a control.
Some studies have used the K ? channel inhibitor XE-199 to identify K v 7.4 currents in arteries. However, Zhong et al. [42] have shown that this compound inhibits K v 1.2, 1.5, and 2.1 in addition to K v 7.4 channels. This is likely the reason that XE-199 produced a contractile response equal to that of 140 mmol/L KCl which was much larger than that produced by the selective K v 7.4 channel inhibitor linopirdine (Fig. 10f) .
Finally, segments maintained under isometric conditions were used for contractile studies as opposed to pressurized segments. While less physiological, isometric preparations provide a similar (although different) view of the effect of K v channel inhibitors on smooth muscle contractile function [57] , it is unlikely, that these two preparations would yield qualitatively different conclusions with regard to the effects of inhibitors on contractile function. However, it is difficult to reconcile the data presented in Fig. 10 . We show that linopirdine produces only a small increase in contraction in the presence of a submaximal concentration of phenylephrine (Fig. 10f) . However, at more negative voltages K v 7.4 makes a substantial contribution to whole cell K ? current (Fig. 10e) . The reason for this discrepancy is not clear but may be related to the actual membrane potential of arterial cells prior to addition of phenylephrine which is not known.
In summary, on the basis of studies including mRNA and protein expression, immunofluorescence, measurements of K v current, and contractile responses to selective inhibitors we have shown that three K v subunit complexes dominate functional K v channels in myocytes from small mesenteric arteries of the rat. One is a combination of K v 1.2 and K v 1.5 a-subunits with K v b1.2 subunits, and another K v 2.1 a-subunits probably associated with K v 9.3 accessory subunits. K v 7.4-containing channels are also functionally present but it is not clear if they are associated with other KCNQ family members (e.g., K v 7.5) or with accessory subunits which have been reported [58] .
